Cargando…
Staphylococcus Aureus carriage and long-term Rituximab treatment for Granulomatosis with polyangiitis
Objective. Chronic nasal carriage of Staphylococcus aureus (SA) increases the risk of relapse while Rituximab (RTX) is an effective agent for inducing and maintaining remission in patients with Granulomatosis with polyangiitis (GPA). We investigated whether B cell depletion and hypogammaglobulinemia...
Autores principales: | Besada, Emilio, Koldingsnes, Wenche, Nossent, Johannes C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485735/ https://www.ncbi.nlm.nih.gov/pubmed/26137431 http://dx.doi.org/10.7717/peerj.1051 |
Ejemplares similares
-
CD4 cell count and CD4/CD8 ratio increase during rituximab maintenance in granulomatosis with polyangiitis patients
por: Besada, Emilio, et al.
Publicado: (2016) -
Successful Treatment With Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A Case Report
por: Toscano Peña, Andrés, et al.
Publicado: (2023) -
Long‐Term Safety of Rituximab in Granulomatosis With Polyangiitis and in Microscopic Polyangiitis
por: Merkel, Peter A., et al.
Publicado: (2021) -
Low immunoglobulin levels increase the risk of severe hypogammaglobulinemia in granulomatosis with polyangiitis patients receiving rituximab
por: Besada, Emilio
Publicado: (2016) -
Nasal carriage of Staphylococcus pseudintermedius in patients with granulomatosis with polyangiitis
por: Kronbichler, Andreas, et al.
Publicado: (2019)